Search Orphan Drug Designations and Approvals
-
Generic Name: | fully human, antagonistic IgG1 monoclonal antibody targeting IL-27 subunit alpha (p28) |
---|---|
Date Designated: | 10/08/2020 |
Orphan Designation: | Treatment of hepatocellular carcinoma (HCC) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Coherus BioSciences, Inc. 333 Twin Dolphin drive, Suite 600 Redwood City, California 94065 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-